Search research articles
Contact Us
Filters
Showing results (1031-1040 of 1,058) with videos related to
Page
of 106
Sort By:
Stroke and Vascular Neurology
|
December 1, 2021
Tranexamic acid for intracerebral haemorrhage within 2 hours of onset: protocol of a phase II randomised placebo-controlled double-blind multicentre trial
Nawaf Yassi, Henry Zhao, Leonid Churilov, et al.
JAMA Neurology
|
May 30, 2023
Symptomatic Intracranial Hemorrhage With Tenecteplase vs Alteplase in Patients With Acute Ischemic Stroke: The Comparative Effectiveness of Routine Tenecteplase vs Alteplase in Acute Ischemic Stroke (CERTAIN) Collaboration
Steven J Warach, Anna Ranta, Joosup Kim, et al.
The Lancet. Haematology
|
June 4, 2026
Prediction of bone marrow fibrosis from complete blood count in myeloproliferative neoplasms (FIBOM-AI): a multicentre machine learning model development and validation study
Marie Donzel, Syrine Khedimallah, Sabrina Barriere, et al.
Blood Advances
|
March 5, 2021
Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study
Damien Luque Paz, Jérémie Riou, Emmanuelle Verger, et al.
Ebiomedicine
|
August 21, 2020
Risk of stroke in hospitalized SARS-CoV-2 infected patients: A multinational study
Shima Shahjouei, Soheil Naderi, Jiang Li, et al.
The Lancet. Neurology
|
April 22, 2024
Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial
Nawaf Yassi, Henry Zhao, Leonid Churilov, et al.
American Journal of Hematology
|
April 6, 2024
Efficacy and safety of mammalian target of rapamycin inhibitors in systemic mastocytosis: A nationwide French pilot study
Josquin Moraly, Julien Rossignol, Claire Rouzaud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 17, 2012
Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs
Robyn M Emanuel, Amylou C Dueck, Holly L Geyer, et al.
International Archives of Allergy and Immunology
|
March 14, 2015
Development of a hypoallergenic recombinant parvalbumin for first-in-man subcutaneous immunotherapy of fish allergy
Laurian Zuidmeer-Jongejan, Hans Huber, Ines Swoboda, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
January 25, 2022
Effective Anti-SARS-CoV-2 Immune Response in Patients With Clonal Mast Cell Disorders
Julien Rossignol, Amani Ouedrani, Cristina Bulai Livideanu, et al.
Page
of 106
Search research articles
Search
Showing results (1031-1040 of 1,058) with videos related to
Sort By:
Page
of 106
Stroke and Vascular Neurology
|
December 1, 2021
Tranexamic acid for intracerebral haemorrhage within 2 hours of onset: protocol of a phase II randomised placebo-controlled double-blind multicentre trial
Nawaf Yassi, Henry Zhao, Leonid Churilov, et al.
JAMA Neurology
|
May 30, 2023
Symptomatic Intracranial Hemorrhage With Tenecteplase vs Alteplase in Patients With Acute Ischemic Stroke: The Comparative Effectiveness of Routine Tenecteplase vs Alteplase in Acute Ischemic Stroke (CERTAIN) Collaboration
Steven J Warach, Anna Ranta, Joosup Kim, et al.
The Lancet. Haematology
|
June 4, 2026
Prediction of bone marrow fibrosis from complete blood count in myeloproliferative neoplasms (FIBOM-AI): a multicentre machine learning model development and validation study
Marie Donzel, Syrine Khedimallah, Sabrina Barriere, et al.
Blood Advances
|
March 5, 2021
Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study
Damien Luque Paz, Jérémie Riou, Emmanuelle Verger, et al.
Ebiomedicine
|
August 21, 2020
Risk of stroke in hospitalized SARS-CoV-2 infected patients: A multinational study
Shima Shahjouei, Soheil Naderi, Jiang Li, et al.
The Lancet. Neurology
|
April 22, 2024
Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial
Nawaf Yassi, Henry Zhao, Leonid Churilov, et al.
American Journal of Hematology
|
April 6, 2024
Efficacy and safety of mammalian target of rapamycin inhibitors in systemic mastocytosis: A nationwide French pilot study
Josquin Moraly, Julien Rossignol, Claire Rouzaud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 17, 2012
Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs
Robyn M Emanuel, Amylou C Dueck, Holly L Geyer, et al.
International Archives of Allergy and Immunology
|
March 14, 2015
Development of a hypoallergenic recombinant parvalbumin for first-in-man subcutaneous immunotherapy of fish allergy
Laurian Zuidmeer-Jongejan, Hans Huber, Ines Swoboda, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
January 25, 2022
Effective Anti-SARS-CoV-2 Immune Response in Patients With Clonal Mast Cell Disorders
Julien Rossignol, Amani Ouedrani, Cristina Bulai Livideanu, et al.
Page
of 106